4553 Stock Overview
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Towa Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,776.00 |
| 52 Week High | JP¥3,240.00 |
| 52 Week Low | JP¥1,703.00 |
| Beta | 0.024 |
| 1 Month Change | -6.34% |
| 3 Month Change | 11.40% |
| 1 Year Change | 45.80% |
| 3 Year Change | 26.30% |
| 5 Year Change | 1.65% |
| Change since IPO | 20.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4553 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -0.1% | 2.7% | 1.8% |
| 1Y | 45.8% | 4.7% | 31.0% |
Return vs Industry: 4553 exceeded the JP Pharmaceuticals industry which returned 4.7% over the past year.
Return vs Market: 4553 exceeded the JP Market which returned 31% over the past year.
Price Volatility
| 4553 volatility | |
|---|---|
| 4553 Average Weekly Movement | 6.6% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4553 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4553's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 4,298 | Itsuro Yoshida | www.towayakuhin.co.jp |
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services.
Towa Pharmaceutical Co., Ltd. Fundamentals Summary
| 4553 fundamental statistics | |
|---|---|
| Market cap | JP¥136.63b |
| Earnings (TTM) | JP¥11.74b |
| Revenue (TTM) | JP¥236.78b |
11.6x
P/E Ratio0.6x
P/S RatioIs 4553 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4553 income statement (TTM) | |
|---|---|
| Revenue | JP¥236.78b |
| Cost of Revenue | JP¥154.71b |
| Gross Profit | JP¥82.07b |
| Other Expenses | JP¥70.34b |
| Earnings | JP¥11.74b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 238.42 |
| Gross Margin | 34.66% |
| Net Profit Margin | 4.96% |
| Debt/Equity Ratio | 131.8% |
How did 4553 perform over the long term?
See historical performance and comparison